v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows From Operating Activities:    
Net loss $ (10,544) $ (11,981)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 6,402 7,646
Amortization of debt discount 296 320
Non-cash operating lease expense 1,237 1,911
Unrealized (gain) loss on investments in equity securities 1,062 (659)
Realized loss on available-for-sale investments 1,044 851
Stock-based compensation expense 2,395 3,700
Loss on disposal of property and equipment 30 4
Change in credit losses 7 (31)
Excess and obsolete inventory 98 145
Change in contingent consideration 15 (5,183)
Changes in operating assets and liabilities:    
Accounts receivable (5,733) 778
Inventories 1,319 (2,305)
Prepaid expenses and other current assets 2,223 394
Deposits 16 (167)
Operating lease liabilities (1,212) (1,288)
Accounts payable and other accrued expenses (596) (783)
Accrued compensation and related expenses 4,061 1,633
Deferred revenue 1,379 699
Net deferred tax liability 236 (26)
Net cash provided by (used in) operating activities 3,735 (4,342)
Cash Flows From Investing Activities:    
Purchases of property and equipment (9,981) (3,168)
Software development costs   (555)
Sales/maturities of short-term investments 29,000 10,000
Patent and trademark costs (301) (355)
Net cash provided by investing activities 18,718 5,922
Cash Flows From Financing Activities:    
Proceeds from exercise of stock options 229 3
Repayment of notes payable (35) (37)
Repayment of finance lease liabilities (109) (155)
Net cash provided by (used in) financing activities 85 (189)
Effect of exchange rates on cash and cash equivalents (120) 681
Net change in cash and cash equivalents 22,418 2,072
Cash and cash equivalents - beginning of period 250,494 45,289
Cash and cash equivalents - end of period 272,912 47,361
Reconciliation of cash and cash equivalents to the condensed consolidated balance sheets:    
Cash and cash equivalents from continuing operations - beginning of period 250,494 34,137
Cash and cash equivalents from discontinued operations (included in current assets held for sale) - beginning of period   11,152
Total cash and cash equivalents - beginning of period 250,494 45,289
Cash and cash equivalents from continuing operations - end of period 272,912 36,102
Cash and cash equivalents from discontinued operations (included in current assets held for sale) - end of period   11,259
Total cash and cash equivalents - end of period 272,912 47,361
Supplemental Disclosure of Cash Flow Information:    
Cash paid for interest 28 36
Cash paid for income taxes 502 408
Supplemental Disclosure of Non-Cash Financing Activities:    
Operating lease right-of-use assets and operating lease liabilities 947 2,286
Net unrealized gain on available-for-sale debt securities 18 808
Reclassification of realized gain (loss) on available-for-sale debt securities to earnings 1,096 854
Paid-in-kind preferred stock dividend 2,000 2,000
Intangible assets included in property and equipment 3,633  
Fixed assets purchases included in accounts payable and accrued liabilities 1,604 189
Contingent consideration reclassed to accounts payable and accrued liabilities   833
Purchase of equipment through finance lease obligation $ 57 $ 39